FDA recall D-0762-2023
Sagent Pharmaceuticals Inc · Class II · drug
Product
Nafcillin for Injection, USP, 1 gram per vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. NDC: 25021-139-10
Reason for recall
Lack of Assurance of Sterility
Distribution
Nationwide USA
Key facts
- Status
- Ongoing
- Initiation date
- 2023-05-19
- Report date
- 2023-05-31
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Schaumburg, IL, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0762-2023